RYM.NZ Stock — Price, Charts & Analysis

Ryman Healthcare Limited (RYM.NZ) has no trailing P/E shown and a forward P/E of 12.07x. This places RYM.NZ in a lower earnings multiple territory based on the valuation data currently available on Worldtickers.

RYM.NZ trades with 12.07x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether RYM.NZ looks overvalued or undervalued.

RYM.NZ's P/E of 12.07x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

RYM.NZ's trailing EPS is -NZ$0.45 and forward EPS is NZ$0.18.

EPS, or earnings per share, shows how much profit Ryman Healthcare Limited generated for each share. RYM.NZ's trailing EPS is -NZ$0.45, and investors usually prefer EPS that is positive and growing over time.

Ryman Healthcare Limited has a market cap of NZ$2.18B, making RYM.NZ a mid-cap stock based on the current market value shown on Worldtickers.

RYM.NZ's latest stock price on Worldtickers is NZ$2.15. The latest move is NZ$0.03 or 1.42%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

RYM.NZ's quote includes a latest price of NZ$2.15. The market open is NZ$2.12. Previous close is NZ$2.12. The intraday range is NZ$2.10 to NZ$2.15.

RYM.NZ is up in the latest quote, with a move of NZ$0.03 or 1.42%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

RYM.NZ generated NZ$854.47M in trailing revenue. Revenue growth is 11.90%, which helps show whether demand is expanding or slowing.

RYM.NZ's revenue growth is 11.90%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, RYM.NZ does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -NZ$171.34M.

Gross margin is 9.45%. Margins show how efficiently Ryman Healthcare Limited turns revenue into profit.

Ryman Healthcare Limited carries NZ$1.60B and holds NZ$20.29M in cash.

RYM.NZ holds NZ$20.29M on its balance sheet.

RYM.NZ's book value per share is NZ$4.02.

RYM.NZ's five-year average dividend yield is 205.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 25.38% of RYM.NZ shares. Insiders hold 12.13% of shares. Ownership mix helps investors understand how much of Ryman Healthcare Limited is held by professional investors and company insiders.

RYM.NZ has 1.02B shares outstanding. Float shares are 1.01B. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for RYM.NZ, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for RYM.NZ is NZ$0.18. Revenue growth is 11.90%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

RYM.NZ's trailing EPS is -NZ$0.45. Forward EPS is NZ$0.18. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

RYM.NZ is in the Healthcare sector. Its earnings multiple is 12.07x. Its latest displayed growth metric is 11.90%. Compare these figures with sector peers before deciding whether Ryman Healthcare Limited is stronger or weaker than average.

RYM.NZ trades at NZ$2.15. The stock trades at 12.07x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Ryman Healthcare Limited's fundamentals.

RYM.NZ risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.34, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

RYM.NZ should be compared with companies in Medical Care Facilities. Its earnings multiple is 12.07x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Ryman Healthcare Limited (RYM.NZ) operates in Healthcare, specifically Medical Care Facilities. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.

RYM.NZ trades on NZSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

RYM.NZ stock is priced in NZD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Ryman Healthcare Limited's official website listed on Worldtickers is www.rymanhealthcare.co.nz. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Ryman Healthcare Limited is headquartered in Christchurch, New Zealand. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

RYM.NZ is in the Healthcare sector and the Medical Care Facilities industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

RYM.NZ has traded between NZ$1.99 and NZ$3.05 over the past 52 weeks. At NZ$2.15, it is 29.51% below the high and 8.04% above the low. The 52-week range helps gauge long-term price momentum.

RYM.NZ is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is NZ$2.19 and its 200-day moving average is NZ$2.45.

RYM.NZ's RSI is 52.26. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

RYM.NZ's latest RSI reading is 52.26, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for RYM.NZ is near NZ$2.03. Key resistance is near NZ$2.34. Breaks above resistance or below support can change the short-term technical setup.

RYM.NZ's nearest reported support level is NZ$2.03. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

RYM.NZ's nearest reported resistance level is NZ$2.34. A breakout above resistance can improve momentum, especially when volume confirms the move.

RYM.NZ trades about 1.25M shares daily on average. The latest displayed volume is 419.95K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

RYM.NZ's MACD is 0.01, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

RYM.NZ is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 52.26 (neutral). MACD is bullish. Nearest support is around NZ$2.03. Resistance is around NZ$2.34. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is NZ$2.12 (1.22% from price). MA50 is NZ$2.19 (-1.93% from price). MA200 is NZ$2.45 (-12.14% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. RYM.NZ's MA20 is NZ$2.12. MA50 is NZ$2.19. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

RYM.NZ's pivot is near NZ$2.11. Support is near NZ$2.03. Resistance is near NZ$2.34. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for RYM.NZ is near NZ$2.09. The next upper resistance zone is near NZ$2.22. These levels help define risk and possible follow-through zones after a breakout or breakdown.

RYM.NZ's Bollinger range is roughly NZ$1.97 to NZ$2.28. Band width is near 14.33%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

RYM.NZ's ATR-based typical daily range is about 2.61%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 419.95K shares. Average volume is about 1.25M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

RYM.NZ's all-time high shown on Worldtickers is NZ$16.21. Its all-time low is NZ$0.06. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

RYM.NZ has a beta of 0.34, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.